Novozymes Investor Relations Material
Access more data
Rest of EMEA
Novozymes develops, produces and sells industrial enzymes, microorganisms and probiotics. The products convert raw materials into food, beverages and biofuels; they also improve the production of crops and plant products, as well as animal feed. Manufacturing microorganisms, enzymes and probiotics for the industrial, biotech and food markets, Novozymes creates innovative solutions that improve their customers' fermentation processes. Their development centres in Europe, USA and Asia help the company to develop consistent and cost-efficient solutions for their partners worldwide.
Key slides for Novozymes
Rubrik's 2024 IPO: What Investors Need To Know
Explore Rubrik's journey to a 2024 IPO, its innovative cybersecurity solutions, and strategic growth, highlighting its impact on the tech sector.
29 Feb 2024
Pricing Power Through Scarcity: A Case Study of Ferrari
Explore how Ferrari's scarcity and brand strength amplify its pricing power, crucial for a luxury company's success.
27 Feb 2024
Jacob Wallenberg: The Chairman of Investor AB
Get to know Jacob Wallenberg, one of the most influential businessmen in Europe and a part of the fifth generation of the Wallenberg family.
28 Feb 2024